Home › Funds › Nantahala Capital Management, LLC › REGN

Nantahala Capital Management, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Nantahala Capital Management, LLC reported holding 31,141 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$23.6M, representing 1.08% of its reported portfolio and ranking #31 among its reported holdings. Nantahala Capital Management, LLC has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)31.14K sh
Reported value held$23.61M
Portfolio Weight1.08%
First reportedQ3 2025
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nantahala Capital Management, LLC's REGN position evolved

Nantahala Capital Management, LLC first disclosed a stake in REGN in Q3 2025 at 40,000 shares (US$22.5M). The position peaked in Q1 2026 at 40,000 shares, worth US$30.9M. Across 5 filings, Nantahala Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 31,141 shares valued at US$23.6M — a reduction of -8,859 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 40.00K $22.49M New
Q4 2025 40.00K $30.87M Hold
Q1 2026 40.00K $30.91M Hold
Q2 2026 40.00K $24.94M Hold
Q3 2026 31.14K $23.61M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 27 other funds we track also report a position in REGN — the largest reported positions include DODGE & COX (US$3.62B), Dodge & Cox (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Nantahala Capital Management, LLC held REGN?

Nantahala Capital Management, LLC has disclosed REGN holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Nantahala Capital Management, LLC's current position in REGN?

As of Q3 2026, Nantahala Capital Management, LLC holds 31.14K shares of REGN (REGENERON PHARMACEUTICALS), valued at $23.61M, representing 1.08% of its reported portfolio and ranking #31.

Has Nantahala Capital Management, LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC reduced its position in REGN. The position peaked in Q1 2026 at 40.00K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include DODGE & COX, Dodge & Cox, Franklin Resources, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.